Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed at cardiotoxicity. [electronic resource]
Producer: 20090428Description: 109-14 p. digitalISSN:- 1473-5741
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Epirubicin -- administration & dosage
- Feasibility Studies
- Female
- Heart -- drug effects
- Humans
- Middle Aged
- Neoplasm Metastasis -- drug therapy
- Paclitaxel -- administration & dosage
- Stroke Volume -- drug effects
- Survival Rate
- Trastuzumab
- Treatment Outcome
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.